Hongwei Cheng

5.8k citations
101 papers · 4.3k indexed · 1 hit paper · h-index 35
Topics
Nanoplatforms for cancer theranostics (31 papers)Hepatocellular Carcinoma Treatment and Prognosis (17 papers)Nanoparticle-Based Drug Delivery (14 papers)
Partner nations
ChinaMacaoUnited States

In The Last Decade

Hongwei Cheng

96 papers receiving 4.2k citations

Hit Papers

OSTEOGENIC ACTIVITY OF THE FOURTEEN TYPES OF HUMAN BONE M...20032026201020182003250500750

Peers

Hongwei Cheng
Comparison fields: 5 of 141
  • Molecular Biology 1.7k
  • Biomedical Engineering 1.3k
  • Surgery 688
  • Pulmonary and Respiratory Medicine 574
  • Biomaterials 545
Replace Nasser Aghdami with:
Nasser Aghdami Iran
Thomas H. Barker United States
Guanbin Song China
Jeong‐Hwa Baek South Korea
Yu‐Ru V. Shih United States
Yao Wang China
John M. Whitelock Australia
Ruth Knüchel Germany
Spyros S. Skandalis Greece
Chao Xie China
Hongwei Cheng relative to Nasser Aghdami Iran Nasser Aghdami's profile →
Citations per field
00.5×4.5×
Nasser Aghdami · 1×
Citations per year

Countries citing papers authored by Hongwei Cheng

Since Specialization
Citations

This map shows the geographic impact of Hongwei Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei Cheng more than expected).

Fields of papers citing papers by Hongwei Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongwei Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei Cheng. The network helps show where Hongwei Cheng may publish in the future.

Co-authorship network of co-authors of Hongwei Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Hongwei Cheng. A scholar is included among the top collaborators of Hongwei Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongwei Cheng. Hongwei Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 0
5 15
6 11
7 8
8 64
9 15
10 7
11 14
12 28
13 6
14 39
15
Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients
0
16 29
17 15
18 151
19
OSTEOGENIC ACTIVITY OF THE FOURTEEN TYPES OF HUMAN BONE MORPHOGENETIC PROTEINS (BMPS)breakdown →
756
20 124

About Hongwei Cheng

Hongwei Cheng is a scholar working on Hepatology, Biomaterials and Biomedical Engineering, having authored 101 papers that have together received 4.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (31 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Nanoparticle-Based Drug Delivery (14 papers). The work is most often cited by research in Urology (285 citations), Biomaterials (545 citations) and Hepatology (243 citations). Hongwei Cheng has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Gang Liu, Tong‐Chuan He, Benjamin N. Breyer, Rex C. Haydon, Wei Jiang, Hue H. Luu, Jung Tak Park, Ying Peng, Frank M. Phillips and Lan Zhou. Their work appears in journals such as Advanced Materials, Journal of Biological Chemistry and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026